BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3369493)

  • 1. Endometriosis developing during tamoxifen therapy.
    Ford MR; Turner MJ; Wood C; Soutter WP
    Am J Obstet Gynecol; 1988 May; 158(5):1119. PubMed ID: 3369493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endometriosis in tamoxifen therapy].
    Fuith LC; Pflanzl W
    Geburtshilfe Frauenheilkd; 1995 Jun; 55(6):354-5. PubMed ID: 7657147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal and pelvic endometriosis presenting as a tumor and associated with tamoxifen therapy: report of a case.
    Hajjar LR; Kim W; Nolan GH; Turner S; Raju UR
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):642-4. PubMed ID: 8377997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometriosis and tamoxifen therapy.
    Morgan MA; Gincherman Y; Mikuta JJ
    Int J Gynaecol Obstet; 1994 Apr; 45(1):55-7. PubMed ID: 7913061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic Atypical Hyperplasia and Endometriosis Following Treatment with Tamoxifen: A Case Report and Review of the Literature.
    Grisdale M; Alghamdi S; Boutross-Tadross O; Luketic L
    J Obstet Gynaecol Can; 2021 Jan; 43(1):85-87. PubMed ID: 32739356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature.
    Cohen I; Altaras MM; Lew S; Tepper R; Beyth Y; Ben-Baruch G
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):443-7. PubMed ID: 7835785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-menopausal endometriosis developed during tamoxifen treatment].
    Le Bouëdec G; Kauffmann P; Pingeon JM; de Latour M; Lemesle P; Dauplat J
    Rev Fr Gynecol Obstet; 1991 May; 86(5):407-10. PubMed ID: 1871504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypoid endometriosis and other benign gynaecological complications associated with Tamoxifen therapy-a case to illustrate features on magnetic resonance imaging.
    Kraft JK; Hughes T
    Clin Radiol; 2006 Feb; 61(2):198-201. PubMed ID: 16439226
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity?
    Cohen I; Beyth Y; Tepper R; Figer A; Shapira J; Cordoba M; Yigael D; Altaras MM
    Gynecol Oncol; 1995 Jul; 58(1):86-91. PubMed ID: 7789896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen and the uterus and endometrium.
    Cano A; Matallin P; Legua V; Tortajada M; Bonilla-Musoles F
    Lancet; 1989 Feb; 1(8634):376. PubMed ID: 18446930
    [No Abstract]   [Full Text] [Related]  

  • 12. Tamoxifen and endometriosis. Case report.
    Buckley CH
    Br J Obstet Gynaecol; 1990 Jul; 97(7):645-6. PubMed ID: 2390510
    [No Abstract]   [Full Text] [Related]  

  • 13. Tamoxifen: use in benign conditions.
    Fentiman IS
    Br J Clin Pract; 1988 Sep; 42(9):384-7. PubMed ID: 3075930
    [No Abstract]   [Full Text] [Related]  

  • 14. Tamoxifen and benign breast problems.
    Fentiman IS; Powles TJ
    Lancet; 1987 Nov; 2(8567):1070-2. PubMed ID: 2889976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen-associated post-menopausal endometriosis.
    Ismail SM; Maulik TG
    Histopathology; 1997 Feb; 30(2):187-91. PubMed ID: 9067744
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen-associated postmenopausal endometriosis.
    Buckley CH
    Histopathology; 1997 Sep; 31(3):296. PubMed ID: 9445841
    [No Abstract]   [Full Text] [Related]  

  • 17. Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure.
    Rose PG; Alvarez B; Maclennan GT
    Am J Obstet Gynecol; 2000 Aug; 183(2):507-8. PubMed ID: 10942499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitotically active leiomyoma of the uterus in a postmenopausal breast cancer patient receiving tamoxifen.
    Liu IF; Yen YS; Cheng YM; Chou CY
    Taiwan J Obstet Gynecol; 2006 Jun; 45(2):167-9. PubMed ID: 17197361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen induced adenomyosis and adenomyomatous endometrial polyp.
    Ugwumadu AH; Bower D; Ho PK
    Br J Obstet Gynaecol; 1993 Apr; 100(4):386-8. PubMed ID: 8494842
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of fibrocystic mastopathy by an antiestrogen, tamoxifen.
    Shaaban MM; Morad F; Hassan Ael R
    Int J Gynaecol Obstet; 1980; 18(5):348-50. PubMed ID: 6110580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.